Daniel J Selig (Daniel Selig)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Urinary Tract Infection

Systematic Review

Molecularly Imprinted

Clostridium Difficile

Top Venues

Journal of personalized medicine

Antibiotics (Basel, Switzerland)

Journal of clinical pharmacy and therapeutics

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel J Selig, Diana Caridha, Martin Evans, Adrian Kress, Charlotte Lanteri, Roseanne Ressner, Jesse DeLuca
Animal Models in Regulatory Breakpoint Determination: Review of New Drug Applications of Approved Antibiotics from 2014-2022. Journal of personalized medicine 14 (1) (2024)
Daniel J Selig, Diana Caridha, Martin Evans, Adrian Kress, Charlotte Lanteri, Roseanne Ressner, Jesse DeLuca
Animal Models in Regulatory Breakpoint Determination: Review of New Drug Applications of Approved Antibiotics from 2014-2022. Journal of personalized medicine 14 (1) (2024)
Daniel J Selig, Diana Caridha, Martin Evans, Adrian Kress, Charlotte Lanteri, Roseanne Ressner, Jesse DeLuca
Animal Models in Regulatory Breakpoint Determination: Review of New Drug Applications of Approved Antibiotics from 2014-2022. Journal of personalized medicine 14 (1) (2024)
Daniel J Selig, Adrian T Kress, Robert J Nadeau, Jesse P DeLuca
Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Daniel J Selig, Adrian T Kress, Robert J Nadeau, Jesse P DeLuca
Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study. Antibiotics (Basel, Switzerland) 12 (3) (2023)
Jonathan D Vignali, Kevin C Pak, Holly R Beverley, Jesse P DeLuca, John W Downs, Adrian T Kress, Brett W Sadowski, Daniel J Selig
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users. Journal of xenobiotics 13 (2) (2023)
David A Kerling, Sarah C Clarke, Jesse P DeLuca, Martin O Evans, Adrian T Kress, Robert J Nadeau, Daniel J Selig
Systematic Review and Meta-Analysis of the Effect of Loop Diuretics on Antibiotic Pharmacokinetics. Pharmaceutics 15 (5) (2023)
Daniel J Selig, Jesse P DeLuca, Kevin K Chung, Kaitlin A Pruskowski, Jeffrey R Livezey, Robert J Nadeau, Elaine D Por, Kevin S Akers
Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Daniel J Selig, Adrian T Kress, Isaiah M Horton, Jeffrey R Livezey, Eliot J Sadik, Jesse P DeLuca
Pharmacokinetics, safety and efficacy of intra-articular non-steroidal anti-inflammatory drug injections for the treatment of osteoarthritis: A narrative review. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Daniel J Selig, Jeffrey R Livezey, Geoffrey C Chin, Jesse P DeLuca, Walter O Guillory Ii, Adrian T Kress, Thomas O Oliver, Elaine D Por
Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System. Military medicine 187 (Suppl 1) (2022)
Daniel J Selig, Kevin S Akers, Kevin K Chung, Kaitlin A Pruskowski, Jeffrey R Livezey, Elaine D Por
Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration. British journal of clinical pharmacology (2021)
Daniel J Selig, Aaron J Brown, Jesse P DeLuca, Adrian T Kress, Jeffrey R Livezey, Thomas G Oliver, Elaine D Por, Rosenie Thelus Jean
Risk of type 2 diabetes mellitus by antimuscarinic agents among adult females receiving care in the military health system. Pharmacoepidemiology and drug safety 29 (12) (2020)
Daniel J Selig, Jesse P DeLuca, Qigui Li, Hsiuling Lin, Ken Nguyen, Shaylyn M Scott, Jason C Sousa, Chau T Vuong, Lisa H Xie, Jeffrey R Livezey
Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin. Drug metabolism and personalized therapy 35 (1) (2020)